- Home
- LSTA vs CASI Comparison
LSTA vs CASI Comparison
Compare LSTA & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- CASI
- Stock Information
- Founded
- LSTA 1980
- CASI 1991
- Country
- LSTA United States
- CASI China
- Employees
- LSTA N/A
- CASI N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- CASI Health Care
- Exchange
- LSTA Nasdaq
- CASI Nasdaq
- Market Cap
- LSTA 24.1M
- CASI 20.5M
- IPO Year
- LSTA N/A
- CASI 1996
- Fundamental
- Price
- LSTA $2.61
- CASI $1.30
- Analyst Decision
- LSTA Strong Buy
- CASI Strong Buy
- Analyst Count
- LSTA 1
- CASI 1
- Target Price
- LSTA $15.00
- CASI $4.00
- AVG Volume (30 Days)
- LSTA 15.8K
- CASI 308.6K
- Earning Date
- LSTA 08-11-2025
- CASI 08-15-2025
- Dividend Yield
- LSTA N/A
- CASI N/A
- EPS Growth
- LSTA N/A
- CASI N/A
- EPS
- LSTA N/A
- CASI N/A
- Revenue
- LSTA $1,000,000.00
- CASI $31,368,000.00
- Revenue This Year
- LSTA N/A
- CASI N/A
- Revenue Next Year
- LSTA N/A
- CASI N/A
- P/E Ratio
- LSTA N/A
- CASI N/A
- Revenue Growth
- LSTA N/A
- CASI 8.39
- 52 Week Low
- LSTA $1.87
- CASI $1.09
- 52 Week High
- LSTA $4.20
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- LSTA 50.61
- CASI 38.95
- Support Level
- LSTA $2.36
- CASI $1.09
- Resistance Level
- LSTA $3.07
- CASI $1.50
- Average True Range (ATR)
- LSTA 0.23
- CASI 0.31
- MACD
- LSTA 0.02
- CASI -0.00
- Stochastic Oscillator
- LSTA 37.50
- CASI 13.39
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.